Mengying Hu PhD

Dr. Mengying Hu earned her PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill, where she built the framework for the design and optimization of core-supported lipid nanoparticles for delivering nucleic acid therapeutics. She then completed postdoctoral training at Weill Cornell Medical College as a TL1 scholar in the Clinical and Translational Science Program, where she uncovered the immune-boosting activities of T cell-derived EVs and EV-DNA. Her work has since expanded to encompass translational research, including but not limited to identifying EV biomarkers for early detection, cancer progression, and treatment responses.